(Q37635115)

English

Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores.

scientific article published on February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19925052%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

Europe PubMed Central

Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19925052%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

0 references

Alexandar Tzankov

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19925052%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Inti Zlobec

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19925052%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Philip Went

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19925052%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Hannes Robl

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19925052%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Sylvia Hoeller

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19925052%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Stephan Dirnhofer

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19925052%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

1 February 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19925052%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Leukemia & Lymphoma

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19925052%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

51

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19925052%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19925052%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

199-212

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19925052%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

The epidemiology of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Rituximab therapy in malignant lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Gene expression profiling of diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Molecular pathogenesis of diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Molecular prognostic factors in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Building an outcome predictor model for diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Prognostic evaluation of nodal diffuse large B cell lymphoma by immunohistochemical profiles with emphasis on CD138 expression as a poor prognostic factor

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Emerging prognostic factors in diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Optimal use of prognostic factors in non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

The clinical significance of CD10 antigen expression in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

CD10 expression in diffuse large B-cell lymphomas does not influence survival

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

REporting recommendations for tumour MARKer prognostic studies (REMARK).

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Prognostic factor research in oncology

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Systematic reviews of evaluations of prognostic variables

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Challenges in prognostic analysis

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Systematic reviews of diagnostic tests in cancer: review of methods and reporting

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Disappearance of prognostic significance of histopathological grading of nodular sclerosing Hodgkin's disease for unselected patients, 1972-92.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Tissue microarray technology: principles, pitfalls and perspectives--lessons learned from hematological malignancies.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Coefficient alpha and the internal structure of tests

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Decision-making studies in patient management.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Receiver operating characteristic studies and measurement errors.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Receiver Operating Characteristic Curves and Their Use in Radiology

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

ROC curves in clinical chemistry: uses, misuses, and possible solutions

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Studies reporting ROC curves of diagnostic and prediction data can be incorporated into meta-analyses using corresponding odds ratios

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Statistics review 13: receiver operating characteristic curves

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

The cost of dichotomising continuous variables

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Evaluating the ROC performance of markers for future events

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Regret graphs, diagnostic uncertainty and Youden's Index.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

The Youden Index and the optimal cut-point corrected for measurement error

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Optimal Cut-point and Its Corresponding Youden Index to Discriminate Individuals Using Pooled Blood Samples

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370338

21 January 2018

Identifiers

10.3109/10428190903370338

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19925052%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19925052%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37635115&oldid=2092635229"